Industry News
Pharmaceutical Industry News
ARIA side effects surface in 40% of patients on Biogen’s Alzheimer’s drug Aduhelm: JAMA
ARIA side effects surface in 40% of patients on Biogen's Alzheimer's drug Aduhelm: JAMA fkansteiner Mon, 11/22/2021 - 15:12
Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging glitch
Sagent Pharmaceuticals recalls injectable seizure med thanks to familiar packaging glitch fkansteiner Mon, 11/22/2021 - 13:34
EsoCap swallows up VC cash to fuel study of topical delivery to the esophagus
EsoCap swallows up VC cash to fuel study of topical delivery to the esophagus ntaylor Mon, 11/22/2021 - 11:47
Topical treatment for chemotherapy pain clears early clinical test, teeing up further study of alternative to oral options
Topical treatment for chemotherapy pain clears early clinical test, teeing up further study of alternative to oral options ntaylor Mon, 11/22/2021 - 11:41
Amgen’s Otezla, Repatha and biosimilars put on notice, with challenging years ahead
Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead aliu Mon, 11/22/2021 - 11:19
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug
Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic.
Sanofi clinches 2nd bellwether win in chemotherapy hair loss litigation
Sanofi clinches 2nd bellwether win in chemotherapy hair loss litigation fkansteiner Mon, 11/22/2021 - 10:40
Pfizer, BioNTech ace long-term test of their COVID vaccine in kids 12 to 15, setting up likely approval
Pfizer, BioNTech ace long-term test of their COVID vaccine in kids 12 to 15, setting up likely approval kdunleavy Mon, 11/22/2021 - 09:28
Sun Pharma yanks thousands of erectile dysfunction tablets after manufacturing mishap
Sun Pharma yanks thousands of erectile dysfunction tablets after manufacturing mishap fkansteiner Mon, 11/22/2021 - 09:03
It’s a wrap: Merck collects enough Acceleron shares for $11.5B buyout despite activist investor defiance
It's a wrap: Merck collects enough Acceleron shares for $11.5B buyout despite activist investor defiance aliu Mon, 11/22/2021 - 05:22
Canada Approves Pfizer’s Covid Vaccine for Kids 5 to 11
The move adds more than 2.8 million young people to those eligible for a shot.
F.D.A. Authorizes Coronavirus Booster Shots for All Adults
If the C.D.C. agrees, adults who received a second shot of the Pfizer or Moderna vaccine at least six months ago could be eligible by this weekend.
F.D.A. Authorizes Covid Booster Shots for All Adults
The Food and Drug Administration authorized Pfizer-BioNTech and Moderna vaccine boosters for those 18 and older, in preparation for holiday travel and cold winter months.
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working? nmissakian Fri, 11/19/2021 - 16:39
CDC vaccine advisers endorse Pfizer, Moderna COVID boosters for all adults
CDC vaccine advisers endorse Pfizer, Moderna COVID boosters for all adults kdunleavy Fri, 11/19/2021 - 15:41
FDA asks for 55 years to complete FOIA request on Pfizer’s COVID-19 vaccine
FDA asks for 55 years to complete FOIA request on Pfizer's COVID-19 vaccine fkansteiner Fri, 11/19/2021 - 15:22
Inflation and Retirement: How to Protect Your Savings
With prices rising at their fastest rate in decades, people in retirement or approaching it should take extra care to protect their savings.
BioMarin’s dwarfism drug Voxzogo could be its next blockbuster, but ethics questions loom over the launch
BioMarin's dwarfism drug Voxzogo could be its next blockbuster, but ethics questions loom over the launch esagonowsky Fri, 11/19/2021 - 11:18
Japan sees ‘drug lag’ as foreign pharmas pass up the market amid pricing pressure, industry group warns
Japan sees ‘drug lag’ as foreign pharmas pass up the market amid pricing pressure, industry group warns aliu Fri, 11/19/2021 - 10:55
Pfizer, Moderna score FDA nods for COVID boosters in all adults, setting up high-stakes CDC meeting
Pfizer, Moderna score FDA nods for COVID boosters in all adults, setting up high-stakes CDC meeting kdunleavy Fri, 11/19/2021 - 09:53